Recent Quotes (30 days)

You have no recent quotes
chg | %

Compass Biotechnologies, Inc.  

(Public, OTCMKTS:COBI)   Watch this stock  
Find more results for OTC:CPBM
0.00030
0.00000 (0.00%)
Sep 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.00
Open     -
Vol / Avg. 0.00/16.88M
Mkt cap 366,960.00
P/E     -
Div/yield     -
EPS -0.01
Shares 1.22B
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Jul '12) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -18.11% -124.06%
Return on average equity - -
Employees 2 -
CDP Score - -

Address

9650 - 20 Avenue
EDMONTON, AB T6N 1G1
Canada
+1-780-9904539 (Phone)
+1-780-6697633 (Fax)

Description

Compass Biotechnologies Inc., formerly Cyplasin BioMedical, Ltd., is a development-stage company. The Company is a biotechnology research and development company. The Company is focusing on the development and commercialization of generic, bio-similar and bio-better drug products. The Company is engaged in the business of developing its licenses for patents pertaining to the technology utilized in the prevention and treatment of hepatitis C. The Company's subsidiary is 1WorldDirect US Inc.

Officers and directors

Garth Likes Chairman of the Board
Joseph Sinkule Chief Executive Officer, President, Chief Operating Officer, Director